Literature DB >> 16005180

Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies.

Lone Storgaard1, Jens Peter Bonde, Jørn Olsen.   

Abstract

Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Reports of an increase in male reproductive disorders in several countries led to the hypothesis that estrogens during fetal life may cause reduced sperm counts, cryptorchidism, hypospadias and testicular cancer. So far the hypothesis is based on animal studies and reports from the wild life. We systematically searched the epidemiological literature for evidence linking indicators of prenatal serum levels of maternal estrogens with sperm density, hypospadias, cryptorchidism and testicular cancer in humans. Indicators of fetal estrogen exposure included direct measurements, recorded intake of hormones (diethylstilbestrol (DES), oral contraceptives (OCs) and estrogens), pregnancy conditions with known deviant estrogen level as for instance twin pregnancies and some environmental exposures. Among 425 papers we reviewed 81 publications with appropriate information. With the possible exception of testicular cancer there is no strong epidemiological evidence to indicate that prenatal exposure to estrogen are linked to disturbed development of the male reproductive organs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005180     DOI: 10.1016/j.reprotox.2005.05.006

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  30 in total

1.  Afterword to Semen Analysis in 21st Century Medicine special issue in Asian Journal of Andrology.

Authors:  David J Handelsman; Trevor G Cooper
Journal:  Asian J Androl       Date:  2010-01       Impact factor: 3.285

2.  Trends in the incidence of cryptorchidism and hypospadias of registry-based data in Korea: a comparison between industrialized areas of petrochemical estates and a non-industrialized area.

Authors:  Sae Chul Kim; Su Kyoung Kwon; Yeon Pyo Hong
Journal:  Asian J Androl       Date:  2010-08-23       Impact factor: 3.285

Review 3.  On environmental threats to male infertility.

Authors:  Allen J Wilcox; Jens Peter E Bonde
Journal:  Asian J Androl       Date:  2013-01-21       Impact factor: 3.285

Review 4.  Minireview: transgenerational epigenetic inheritance: focus on endocrine disrupting compounds.

Authors:  Emilie F Rissman; Mazhar Adli
Journal:  Endocrinology       Date:  2014-06-02       Impact factor: 4.736

5.  Reproductive toxicity of linuron following gestational exposure in rats and underlying mechanisms.

Authors:  Hongwei Ding; Wei Zheng; Hua Han; Xiyin Hu; Binli Hu; Feng Wang; Liyu Su; Hong Li; Yan Li
Journal:  Toxicol Lett       Date:  2016-12-19       Impact factor: 4.372

Review 6.  Microfluidics for sperm analysis and selection.

Authors:  Reza Nosrati; Percival J Graham; Biao Zhang; Jason Riordon; Alexander Lagunov; Thomas G Hannam; Carlos Escobedo; Keith Jarvi; David Sinton
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

Review 7.  Untangling the association between environmental endocrine disruptive chemicals and the etiology of male genitourinary cancers.

Authors:  Tiffani J Houston; Rita Ghosh
Journal:  Biochem Pharmacol       Date:  2019-12-06       Impact factor: 5.858

8.  Gestational bisphenol A exposure and testis development.

Authors:  Cecilia Williams; Maria Bondesson; Dimitry N Krementsov; Cory Teuscher
Journal:  Endocr Disruptors (Austin)       Date:  2014

Review 9.  Maternal body mass index and risk of testicular cancer in male offspring: a systematic review and meta-analysis.

Authors:  Shama S Alam; Marie M Cantwell; Chris R Cardwell; Michael B Cook; Liam J Murray
Journal:  Cancer Epidemiol       Date:  2010-08-26       Impact factor: 2.984

Review 10.  [Testicular cancer - a matter of geography? Epidemiology and etiopathogenesis of germ cell tumors].

Authors:  G Mikuz
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.